Tumor immune microenvironment of EGFR-mutant non-small-cell lung cancer and its impact on therapeutic efficacy

被引：4
|
作者：
Matsumoto, Yoshiya [1 ,2 ]
Koh, Yasuhiro [2 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Dept Resp Med, Osaka, Japan
[2] Wakayama Med Univ, Internal Med 3, Wakayama, Japan
来源：
IMMUNOTHERAPY | 2020年 / 12卷 / 07期
关键词：
epidermal growth factor receptor; non-small-cell lung cancer; tumor microenvironment; tumor mutational burden; PD-L1; EXPRESSION; MUTATION INCIDENCE; OPEN-LABEL; PHASE IB; DOCETAXEL; NIVOLUMAB; ATEZOLIZUMAB; BLOCKADE; INFILTRATION; CHEMOTHERAPY;
D O I：
10.2217/imt-2019-0213
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：431 / 438
页数：8
相关论文
共 50 条
  • [31] Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR-mutated non-small cell lung cancer
    Yamada, Tadaaki
    Hirai, Soichi
    Katayama, Yuki
    Yoshimura, Akihiro
    Shiotsu, Shinsuke
    Watanabe, Satoshi
    Kikuchi, Toshiaki
    Hirose, Kazuki
    Kubota, Yutaka
    Chihara, Yusuke
    Harada, Taishi
    Tanimura, Keiko
    Takeda, Takayuki
    Tamiya, Nobuyo
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    CANCER MEDICINE, 2019, 8 (04): : 1521 - 1529
  • [32] Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer
    Kim, Chang Gon
    Kim, Gamin
    Kim, Kyung Hwan
    Park, Seyeon
    Shin, Sunhye
    Yeo, Dahee
    Shim, Hyo Sup
    Yoon, Hong In
    Park, Seong Yong
    Ha, Sang-Jun
    Kim, Hye Ryun
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (12)
  • [33] Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis
    Yoshimura, Akihiro
    Yamada, Tadaaki
    Tsuji, Taisuke
    Hamashima, Ryosuke
    Shiotsu, Shinsuke
    Yuba, Tatsuya
    Takumi, Chieko
    Uchino, Junji
    Hiraoka, Noriya
    Takayama, Koichi
    THORACIC CANCER, 2019, 10 (03) : 557 - 563
  • [34] Efficacy analysis of immunotherapy-based combinations for patients with EGFR-mutant advanced non-small cell lung cancer after TKI failure
    Li, Meifang
    Lin, Cheng
    Lin, Jinghui
    Chen, Shijie
    Weng, Lihong
    He, Zhiyong
    ONCOLOGY LETTERS, 2024, 28 (05)
  • [35] Is It Time to Implement Adjuvant Targeted Therapy in EGFR-Mutant Non-Small-Cell Lung Cancer?
    Kulkarni, Amit A.
    Naqash, Abdul Rafeh
    Puri, Sonam
    Dienstmann, Rodrigo
    JCO PRECISION ONCOLOGY, 2021, 5 : 408 - 414
  • [36] Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors
    Eiki Ichihara
    Daijiro Harada
    Koji Inoue
    Takuo Shibayama
    Shinobu Hosokawa
    Daizo Kishino
    Shingo Harita
    Nobuaki Ochi
    Naohiro Oda
    Naofumi Hara
    Katsuyuki Hotta
    Yoshinobu Maeda
    Katsuyuki Kiura
    Cancer Immunology, Immunotherapy, 2021, 70 : 101 - 106
  • [37] Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigm
    Nishino, Mizuki
    Wakai, Satoshi
    Hida, Tomoyuki
    Dahlberg, Suzanne E.
    Ozaki, Masahiro
    Hatabu, Hiroto
    Tachizaki, Hisashi
    Johnson, Bruce E.
    EUROPEAN JOURNAL OF RADIOLOGY, 2018, 109 : 68 - 76
  • [38] The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases
    Kitadai, Rui
    Okuma, Yusuke
    Hakozaki, Taiki
    Hosomi, Yukio
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 777 - 785
  • [39] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
    Gen, Soei
    Tanaka, Ichidai
    Morise, Masahiro
    Koyama, Junji
    Kodama, Yuta
    Matsui, Akira
    Miyazawa, Ayako
    Hase, Tetsunari
    Hibino, Yoshitaka
    Yokoyama, Toshihiko
    Kimura, Tomoki
    Yoshida, Norio
    Sato, Mitsuo
    Hashimoto, Naozumi
    BMC CANCER, 2022, 22 (01)
  • [40] The resistance mechanisms and treatment strategies for EGFR-mutant advanced non-small-cell lung cancer
    Zhong, Wen-Zhao
    Zhou, Qing
    Wu, Yi-Long
    ONCOTARGET, 2017, 8 (41) : 71358 - 71370
12345